- Home
- PEV vs BCDA Comparison
PEV vs BCDA Comparison
Compare PEV & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEV
- BCDA
- Stock Information
- Founded
- PEV 2002
- BCDA N/A
- Country
- PEV United States
- BCDA United States
- Employees
- PEV N/A
- BCDA N/A
- Industry
- PEV Auto Manufacturing
- BCDA Biotechnology: Pharmaceutical Preparations
- Sector
- PEV Consumer Discretionary
- BCDA Health Care
- Exchange
- PEV Nasdaq
- BCDA Nasdaq
- Market Cap
- PEV 10.9M
- BCDA 9.4M
- IPO Year
- PEV 2022
- BCDA N/A
- Fundamental
- Price
- PEV $0.30
- BCDA $2.10
- Analyst Decision
- PEV
- BCDA Strong Buy
- Analyst Count
- PEV 0
- BCDA 1
- Target Price
- PEV N/A
- BCDA $25.00
- AVG Volume (30 Days)
- PEV 6.5M
- BCDA 94.5K
- Earning Date
- PEV 05-22-2025
- BCDA 05-13-2025
- Dividend Yield
- PEV N/A
- BCDA N/A
- EPS Growth
- PEV N/A
- BCDA N/A
- EPS
- PEV 0.06
- BCDA N/A
- Revenue
- PEV $26,119,000.00
- BCDA $58,000.00
- Revenue This Year
- PEV N/A
- BCDA N/A
- Revenue Next Year
- PEV N/A
- BCDA N/A
- P/E Ratio
- PEV $5.97
- BCDA N/A
- Revenue Growth
- PEV 424.69
- BCDA N/A
- 52 Week Low
- PEV $0.20
- BCDA $1.63
- 52 Week High
- PEV $1.39
- BCDA $6.15
- Technical
- Relative Strength Index (RSI)
- PEV 37.05
- BCDA 38.59
- Support Level
- PEV $0.34
- BCDA $2.45
- Resistance Level
- PEV $0.85
- BCDA $2.95
- Average True Range (ATR)
- PEV 0.10
- BCDA 0.23
- MACD
- PEV -0.04
- BCDA -0.06
- Stochastic Oscillator
- PEV 0.71
- BCDA 6.59
About PEV Phoenix Motor Inc.
Phoenix Motor Inc is an electrification solutions provider for the commercial vehicle industry as well as other industries. It designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium-duty electric vehicles (EVs) and markets and sells electric vehicle chargers for the commercial and residential markets. The company operates two primary brands, Phoenix Motorcars, which focuses on commercial products including medium-duty electric vehicles, chargers, and electric forklifts, and EdisonFuture which intends to offer light-duty electric vehicles.
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).